19-21 ottobre 2007, Jolly Hotel, Trieste
Cancer, cell death and differentiation
New approaches in cancer therapy
RELATORI e MODERATORINiki J. Agnantis, Institute of Pathology, University Joannina-GreeceMyron Arlen, International Bioimmune Systems, New York-USAVivian Barak, Hadassah Medical Organization, Jerusalem-IsraelPier Mario Biava, IRCCS Multimedica Milano-ItalyGeorge D. Birkmayer, Medical Chemistry Dpt, University Graz-AustriaMariano Bizzarri, University La Sapienza, Roma-ItalyFabio Burigana, GP, Gastroenterology specialist, Trieste-ItalyAndrea CalandrelliNicoletta Colombo, Istituto Oncologico Europeo, Milano-ItalyFilippo Conti, University La Sapienza, Roma-ItalyAgostino Cortellezzi, IRCCS Ospedale Maggiore, Policlinico, Milano-ItalyMario CristofoliniFranco Desiderio Oncological prevention service, AUS, Rimini-ItalyAugusto B. Federici, IRCCS Ospedale Maggiore, Policlinico, Milano-ItalyStefano FelettiSecondo Guaschino, Gynecologic Dept., University of Trieste-ItalyEmilio Imparato, Policlinico San Matteo, IRCCS, Pavia-ItalyAlberto Laffranchi, IRCCS Istituto Nazionale Tumori, Milano-ItalyGiorgio Lambertenghi Deliliers, Centro Trapianti Midollo, Milano-ItalyMoti Levy, Clalit Complementary Medicine, IsraelAngelo Maggioni, Istituto Oncologico Europeo, Milano-ItalyLeonardo Marini, Studio Dermochirurgico di Trieste-ItalyMauro Melato, Anatomia Patologica, Ospedali Gorizia e Monfalcone-ItalyAlfredo Miccheli, University La Sapienza, Roma-ItalyLuigi Moro, Biochemical Dept., University of Trieste-ItalyGiorgio Mustacchi, Medical Oncology, Cancer Center, Trieste-ItalyAntonino Neri, IRCCS Ospedale Maggiore, Policlinico, Milano-ItalyFrancesco Onida, IRCCS Ospedale Maggiore, Policlinico, Milano-ItalyA.U. Ramakrishnan Beppe Rocca,Policlinico Mangiagalli e Regina Elena, Milano-ItalyIsaac Roisman, Breast Unit Horev Medical Center, Haifa-IsraelStewart Sell, Wadsworth Research Center Albany, New York-USAMario Sideri, Istituto Oncologico Europeo, Milano-ItalyArsenio Spinillo, IRCCS Policlinico San Matteo, Pavia-ItalyA. Tommasini, University La Sapienza, Roma-Italy
19th October
08.30 – 10.30 REGISTRATION
10,30 – 11,00 Opening Ceremony: WELCOME ADDRESSES
Giorgio Mustacchi, Mauro Melato
CONFERENCE PROFILE: Pier Mario Biava
11,00 – 11,30 KEYNOTE LECTURE
Giorgio Lambertenghi Deliliers
Evolving strategies and new indications of hemopoietic stem cell transplantation
1st Session: PROGRESS IN BLOOD CANCER
11,30 – 13,00
Chairpersons: Stewart Sell, Giorgio Lambertenghi Deliliers
A. Neri Biological markers in the characterization of multiple myeloma
A. Cortellezzi Advances in clinical management of chronic lymphatic leukemia
F. Onida Novel therapeutic approaches in cutaneous lymphomas
A. Federici Thrombotic events in hematological malignancies
13,00 – 14,30 Lunch
2nd Session: STEM CELL DIFFERENTIATION AND CANCER
14,30 – 16,00
Chairpersons: Pier Mario Biava, Mariano Bizzarri, Luigi Moro
S. Sell Stem cell and cancer
P.M. Biava Stem cell differentiation stage factors in tumor growth control
M. Bizzarri Synergy between stem cell differentiation stage factors and
chemotherapeutic agents in tumor growth control.
16,00 – 16,30 Coffee break and Poster Session
3rd Session: METABOLOMICS AND CANCER
16,30 – 18,00
Chairpersons: Filippo Conti, Alfredo Miccheli
F. Conti The role of metabolomics in the study of cancer
A. Miccheli The most important alterations in the biological pathways of cancer
diseases
A. Tommasini Metabolism in cancer diseases
20th October
4th Session: GENITO-URINARY TRACT TUMORS
09,00 – 11,00
Chairpersons: Emilio Imparato, Secondo Guaschino
M. Sideri Human papillomavirus vaccination
A. Spinillo Cervical cancerogenesis in HIV sieropositive women
A biological model
A. Maggioni The role of robotic surgery in gynecologic oncology
N. Colombo Biologic therapies in ovarian cancer
11,00 – 11,15 Coffee break
5th Session: BREAST CANCER
11,15 – 13,00
Chairpersons: Niki J. Agnantis, Vivian Barak
N. J. Agnantis Apoptosis, cell proliferation, bcl 2 and p53 in the multistep
process of breast cancer
I. Roisman Update management in inflammatory breast cancer
V. Barak Tumor markers in breast cancer
More authors
6th Session: INTEGRATED THERAPIES OF CANCER
14,30 – 16,00
Chairpersons: Moti Levy, I. Roisman
M. Levy Complementary medicine in the cancer patients’ care
A. Laffranchi Chemotherapy induced peripheral neuropathy: the homeopathic
treatment as a possible way
F. Desiderio Clinical research on homeopathic remedies applied in oncology in
public hospitals
A.U. Ramakrishnan The Ramakrishnan method: a homeopathic approach
16,00 – 16,30 Coffee break and Poster Session
7th Session: INTEGRATED THERAPIES OF CANCER
16,15 – 18,00
Chairpersons: Beppe Rocca, Fabio Burigana
B. Rocca Quantum physics, integrated medicine and cancer
F. Burigana Non molecular information: plausible hypothesis?
More authors
21st October
8th Session: INTEGRATED THERAPIES OF CANCER
09,00 – 11,00
Chairpersons: George Birkmayer, Myron Arlen
G. Birkmayer: The role of NADPH in cancer therapy
M. Arlen Cancer vaccines
More authors
11,00 – 11,15 Coffee break
9th Session: Skin Cancer
11,15 – 13,00
Chairperson: Leonardo Marini
L. Marini Non melanocitic skin neoplasies
M. Cristofolini Epidemiology of skin tumors
S. Feletti Melanoma
13,00 – 13,15 Conference conclusions
Fonte: IATMO, Int. Academy of Tumor Marker Oncology
